Cart
sales@molnova.com
Demethoxydeacetoxypseudolaric acid B
CAS No. 82508-36-9
Demethoxydeacetoxypseudolaric acid B( —— )
Catalog No. M22958 CAS No. 82508-36-9
Demethoxydeacetoxypseudolaric acid B's the metabolic reaction of TDA in vivo is mainly occurred in blood and contributes to be the hydrolysis of plasma esterase to ester bond, as well as the glucosylation reaction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 202 | In Stock |
|
| 5MG | 188 | In Stock |
|
| 10MG | 312 | In Stock |
|
| 25MG | 524 | In Stock |
|
| 50MG | 732 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDemethoxydeacetoxypseudolaric acid B
-
NoteResearch use only, not for human use.
-
Brief DescriptionDemethoxydeacetoxypseudolaric acid B's the metabolic reaction of TDA in vivo is mainly occurred in blood and contributes to be the hydrolysis of plasma esterase to ester bond, as well as the glucosylation reaction.
-
DescriptionDemethoxydeacetoxypseudolaric acid B's the metabolic reaction of TDA in vivo is mainly occurred in blood and contributes to be the hydrolysis of plasma esterase to ester bond, as well as the glucosylation reaction.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number82508-36-9
-
Formula Weight376.4
-
Molecular FormulaC20H24O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=CC[C@@]([C@@](CC1)(O)[C@]2([H])[C@@](C)(/C=C/C=C(C(O)=O)\C)O3)(CC2)C3=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Liu P , Guo H Z , Sun J H , et al. [Metabolic pathway and metabolites of total diterpene acid isolated from Pseudolarix kaempferi].[J]. Yao Xue Xue Bao, 2014, 49(8):1169-1174.
molnova catalog
related products
-
Pinusolide
Pinusolide is a platelet activating factor ( PAF) antagonist, it may prove of therapeutic value in the treatment of hypotension, it has antileukemic potential, and could be used to treat neurodegenerative diseases.
-
PRMT6-IN-3
PRMT6-IN-3 is a selective PRMT6 inhibitor with an IC50 value of 192 nM.PRMT6-IN-3 has anticancer activity and induces apoptosis in cancer cells.
-
BI-4732
BI-4732 is a potent, highly BBB-permeable EGFR inhibitor that is active against multiple EGFR mutations (E19del, L858R, and T790M), including C797S.
